Abstract
To the Editor: Dr. Murray F. Brennan has written an interesting, accurate, but somewhat ambivalent article on total parenteral nutrition (TPN) for the patient with cancer (August 13 issue).1 He opens with a discussion of the cost of the technique to the patient, outlines several randomized, prospective trials involving approximately 700 patients in whom TPN did not improve relations between the tumor and the host, yet closes with the statement, "TPN is a major tool in the management of cancer." If his paper were to be criticized, the reason would be that Dr. Brennan has failed to resolve this conflict: . . .

This publication has 6 references indexed in Scilit: